CPNP 2021 industry supported symposia are scientific programs developed for educational purposes. All symposia at CPNP 2021 are designed for the psychiatric pharmacist and are included in participant registration fees. All symposia are in compliance with Accreditation Council for Pharmacy Education (ACPE) criteria for planning and implementation and provide 1.5 contact hours of ACPE credit.
There have been tremendous advances recently in the options available for treating bipolar disorder. In this compelling symposium, we will explore some of those advances and strategies for implementing them into clinical practice. The latest evidence-based diagnostic guidelines and treatments for bipolar depression will be deliberated and investigated. Novel agents and notable achievements in the treatment of disorders across the bipolar spectrum with potential applications from depression with mixed features to psychotic mania will also be discussed.
*Session access will open when the session is live on Tuesday, April 20.
Strategies to Improve Patient Outcomes in Bipolar Depression
Faculty: Roger S. McIntyre, MD, FRCPC
Treatment of Bipolar Spectrum Disorders: A Look Towards the Future
Faculty: Stephen M. Stahl, MD, PhD, DSc (Hon.)
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Tardive dyskinesia (TD) continues to significantly impact patient quality of life, affecting their social and work lives and contributing to high rates of antipsychotic nonadherence. Recent guidelines and expert consensus updates have highlighted the importance of early TD identification for rapid treatment initiation, thus improving patient outcomes. In this program, an expert psychiatrist and pharmacist will provide you with a broader knowledge of TD symptoms across multiple levels of symptom severity, key clinical trial data, and guideline and expert consensus updates.
In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
North American Center for Continuing Medical Education (NACCME), LLC, an HMP Global Company
Educational grants from Neurocrine Biosciences and Teva Pharmaceuticals